Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-day Concomitant vs 10-day Sequential Therapy for H. pylori
NCT01544517Phase 3Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Jan 2011
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in Helicobacter pylori infection, sponsored by University of Campania Luigi Vanvitelli. Started Jan 2011; status: completed.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01544517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544517.